6TXE
Crystal structure of tetrameric human wt-SAMHD1 (residues 109-626) with GTP, dATP, dTMPNPP and Mg
Summary for 6TXE
Entry DOI | 10.2210/pdb6txe/pdb |
Related | 6TX0 6TXA 6TXC |
Descriptor | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1, FE (III) ION, MAGNESIUM ION, ... (7 entities in total) |
Functional Keywords | triphosphohydrolase, metallo-enzyme, binuclear, hd, hydrolase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 16 |
Total formula weight | 989997.65 |
Authors | Morris, E.R.,Kunzelmann, S.,Caswell, S.J.,Arnold, L.H.,Purkiss, A.G.,Kelly, G.,Taylor, I.A. (deposition date: 2020-01-14, release date: 2020-06-24, Last modification date: 2024-01-24) |
Primary citation | Morris, E.R.,Caswell, S.J.,Kunzelmann, S.,Arnold, L.H.,Purkiss, A.G.,Kelly, G.,Taylor, I.A. Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis. Nat Commun, 11:3165-3165, 2020 Cited by PubMed Abstract: SAMHD1 regulates cellular 2'-deoxynucleoside-5'-triphosphate (dNTP) homeostasis by catalysing the hydrolysis of dNTPs into 2'-deoxynucleosides and triphosphate. In CD4 myeloid lineage and resting T-cells, SAMHD1 blocks HIV-1 and other viral infections by depletion of the dNTP pool to a level that cannot support replication. SAMHD1 mutations are associated with the autoimmune disease Aicardi-Goutières syndrome and hypermutated cancers. Furthermore, SAMHD1 sensitises cancer cells to nucleoside-analogue anti-cancer therapies and is linked with DNA repair and suppression of the interferon response to cytosolic nucleic acids. Nevertheless, despite its requirement in these processes, the fundamental mechanism of SAMHD1-catalysed dNTP hydrolysis remained unknown. Here, we present structural and enzymological data showing that SAMHD1 utilises an active site, bi-metallic iron-magnesium centre that positions a hydroxide nucleophile in-line with the P-O bond to catalyse phosphoester bond hydrolysis. This precise molecular mechanism for SAMHD1 catalysis, reveals how SAMHD1 down-regulates cellular dNTP and modulates the efficacy of nucleoside-based anti-cancer and anti-viral therapies. PubMed: 32576829DOI: 10.1038/s41467-020-16983-2 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.19 Å) |
Structure validation
Download full validation report